nodes	percent_of_prediction	percent_of_DWPC	metapath
Fosphenytoin—CYP2C8—Paclitaxel—ovarian cancer	0.0835	0.212	CbGbCtD
Fosphenytoin—CYP3A4—Topotecan—ovarian cancer	0.0684	0.173	CbGbCtD
Fosphenytoin—CYP2B6—Doxorubicin—ovarian cancer	0.0594	0.151	CbGbCtD
Fosphenytoin—CYP2C9—Paclitaxel—ovarian cancer	0.0583	0.148	CbGbCtD
Fosphenytoin—CYP3A4—Vinorelbine—ovarian cancer	0.0482	0.122	CbGbCtD
Fosphenytoin—CYP3A4—Paclitaxel—ovarian cancer	0.0339	0.0859	CbGbCtD
Fosphenytoin—CYP3A4—Docetaxel—ovarian cancer	0.0245	0.0621	CbGbCtD
Fosphenytoin—CYP3A4—Doxorubicin—ovarian cancer	0.0183	0.0463	CbGbCtD
Fosphenytoin—Diplopia—Doxorubicin—ovarian cancer	0.000541	0.000893	CcSEcCtD
Fosphenytoin—Osteoarthritis—Doxorubicin—ovarian cancer	0.000541	0.000893	CcSEcCtD
Fosphenytoin—Liver function test abnormal—Epirubicin—ovarian cancer	0.00054	0.000891	CcSEcCtD
Fosphenytoin—Rash—Melphalan—ovarian cancer	0.000539	0.000891	CcSEcCtD
Fosphenytoin—Dermatitis—Melphalan—ovarian cancer	0.000539	0.00089	CcSEcCtD
Fosphenytoin—Chills—Docetaxel—ovarian cancer	0.000538	0.000888	CcSEcCtD
Fosphenytoin—Cough—Paclitaxel—ovarian cancer	0.000537	0.000887	CcSEcCtD
Fosphenytoin—Asthenia—Vinorelbine—ovarian cancer	0.000536	0.000885	CcSEcCtD
Fosphenytoin—Orthostatic hypotension—Epirubicin—ovarian cancer	0.000534	0.000882	CcSEcCtD
Fosphenytoin—Convulsion—Paclitaxel—ovarian cancer	0.000533	0.000881	CcSEcCtD
Fosphenytoin—Affect lability—Doxorubicin—ovarian cancer	0.000532	0.000879	CcSEcCtD
Fosphenytoin—Migraine—Doxorubicin—ovarian cancer	0.000532	0.000879	CcSEcCtD
Fosphenytoin—Hypokalaemia—Epirubicin—ovarian cancer	0.000532	0.000879	CcSEcCtD
Fosphenytoin—Hypertension—Paclitaxel—ovarian cancer	0.000532	0.000878	CcSEcCtD
Fosphenytoin—Pruritus—Vinorelbine—ovarian cancer	0.000529	0.000873	CcSEcCtD
Fosphenytoin—Arthralgia—Paclitaxel—ovarian cancer	0.000524	0.000866	CcSEcCtD
Fosphenytoin—Myalgia—Paclitaxel—ovarian cancer	0.000524	0.000866	CcSEcCtD
Fosphenytoin—Face oedema—Doxorubicin—ovarian cancer	0.000522	0.000862	CcSEcCtD
Fosphenytoin—Nausea—Topotecan—ovarian cancer	0.000519	0.000857	CcSEcCtD
Fosphenytoin—Discomfort—Paclitaxel—ovarian cancer	0.000518	0.000855	CcSEcCtD
Fosphenytoin—Gastritis—Epirubicin—ovarian cancer	0.000517	0.000854	CcSEcCtD
Fosphenytoin—Muscular weakness—Epirubicin—ovarian cancer	0.000516	0.000851	CcSEcCtD
Fosphenytoin—Cardiac arrest—Doxorubicin—ovarian cancer	0.000514	0.000849	CcSEcCtD
Fosphenytoin—Dry mouth—Paclitaxel—ovarian cancer	0.000513	0.000847	CcSEcCtD
Fosphenytoin—Mood swings—Doxorubicin—ovarian cancer	0.000512	0.000846	CcSEcCtD
Fosphenytoin—Diarrhoea—Vinorelbine—ovarian cancer	0.000511	0.000844	CcSEcCtD
Fosphenytoin—Dysgeusia—Docetaxel—ovarian cancer	0.000511	0.000844	CcSEcCtD
Fosphenytoin—Ataxia—Doxorubicin—ovarian cancer	0.000509	0.00084	CcSEcCtD
Fosphenytoin—Nausea—Melphalan—ovarian cancer	0.000508	0.000839	CcSEcCtD
Fosphenytoin—Confusional state—Paclitaxel—ovarian cancer	0.000507	0.000837	CcSEcCtD
Fosphenytoin—Asthma—Epirubicin—ovarian cancer	0.000505	0.000834	CcSEcCtD
Fosphenytoin—Influenza—Epirubicin—ovarian cancer	0.000505	0.000834	CcSEcCtD
Fosphenytoin—Dysphagia—Epirubicin—ovarian cancer	0.000505	0.000834	CcSEcCtD
Fosphenytoin—Back pain—Docetaxel—ovarian cancer	0.000505	0.000834	CcSEcCtD
Fosphenytoin—Dehydration—Doxorubicin—ovarian cancer	0.000503	0.000831	CcSEcCtD
Fosphenytoin—Anaphylactic shock—Paclitaxel—ovarian cancer	0.000503	0.00083	CcSEcCtD
Fosphenytoin—Muscle spasms—Docetaxel—ovarian cancer	0.000502	0.000829	CcSEcCtD
Fosphenytoin—Liver function test abnormal—Doxorubicin—ovarian cancer	0.000499	0.000825	CcSEcCtD
Fosphenytoin—Infection—Paclitaxel—ovarian cancer	0.000499	0.000825	CcSEcCtD
Fosphenytoin—Shock—Paclitaxel—ovarian cancer	0.000494	0.000817	CcSEcCtD
Fosphenytoin—Dizziness—Vinorelbine—ovarian cancer	0.000494	0.000816	CcSEcCtD
Fosphenytoin—Orthostatic hypotension—Doxorubicin—ovarian cancer	0.000494	0.000816	CcSEcCtD
Fosphenytoin—Hypokalaemia—Doxorubicin—ovarian cancer	0.000492	0.000813	CcSEcCtD
Fosphenytoin—Thrombocytopenia—Paclitaxel—ovarian cancer	0.000492	0.000813	CcSEcCtD
Fosphenytoin—Tachycardia—Paclitaxel—ovarian cancer	0.00049	0.00081	CcSEcCtD
Fosphenytoin—Bronchitis—Epirubicin—ovarian cancer	0.000486	0.000802	CcSEcCtD
Fosphenytoin—Hyperhidrosis—Paclitaxel—ovarian cancer	0.000486	0.000802	CcSEcCtD
Fosphenytoin—Anaemia—Docetaxel—ovarian cancer	0.000482	0.000797	CcSEcCtD
Fosphenytoin—Anorexia—Paclitaxel—ovarian cancer	0.000479	0.000791	CcSEcCtD
Fosphenytoin—Gastritis—Doxorubicin—ovarian cancer	0.000479	0.000791	CcSEcCtD
Fosphenytoin—Muscular weakness—Doxorubicin—ovarian cancer	0.000477	0.000788	CcSEcCtD
Fosphenytoin—Vomiting—Vinorelbine—ovarian cancer	0.000475	0.000785	CcSEcCtD
Fosphenytoin—Dysuria—Epirubicin—ovarian cancer	0.000472	0.00078	CcSEcCtD
Fosphenytoin—Rash—Vinorelbine—ovarian cancer	0.000471	0.000778	CcSEcCtD
Fosphenytoin—Dermatitis—Vinorelbine—ovarian cancer	0.000471	0.000777	CcSEcCtD
Fosphenytoin—Hypotension—Paclitaxel—ovarian cancer	0.00047	0.000776	CcSEcCtD
Fosphenytoin—Headache—Vinorelbine—ovarian cancer	0.000468	0.000773	CcSEcCtD
Fosphenytoin—Syncope—Docetaxel—ovarian cancer	0.000468	0.000773	CcSEcCtD
Fosphenytoin—Influenza—Doxorubicin—ovarian cancer	0.000467	0.000772	CcSEcCtD
Fosphenytoin—Asthma—Doxorubicin—ovarian cancer	0.000467	0.000772	CcSEcCtD
Fosphenytoin—Dysphagia—Doxorubicin—ovarian cancer	0.000467	0.000772	CcSEcCtD
Fosphenytoin—Leukopenia—Docetaxel—ovarian cancer	0.000467	0.000772	CcSEcCtD
Fosphenytoin—Palpitations—Docetaxel—ovarian cancer	0.000461	0.000762	CcSEcCtD
Fosphenytoin—Photosensitivity reaction—Epirubicin—ovarian cancer	0.000461	0.000762	CcSEcCtD
Fosphenytoin—Loss of consciousness—Docetaxel—ovarian cancer	0.000459	0.000758	CcSEcCtD
Fosphenytoin—Musculoskeletal discomfort—Paclitaxel—ovarian cancer	0.000458	0.000756	CcSEcCtD
Fosphenytoin—Hyperglycaemia—Epirubicin—ovarian cancer	0.000456	0.000753	CcSEcCtD
Fosphenytoin—Cough—Docetaxel—ovarian cancer	0.000455	0.000752	CcSEcCtD
Fosphenytoin—Insomnia—Paclitaxel—ovarian cancer	0.000455	0.000751	CcSEcCtD
Fosphenytoin—Pneumonia—Epirubicin—ovarian cancer	0.000453	0.000748	CcSEcCtD
Fosphenytoin—Convulsion—Docetaxel—ovarian cancer	0.000452	0.000747	CcSEcCtD
Fosphenytoin—Paraesthesia—Paclitaxel—ovarian cancer	0.000451	0.000745	CcSEcCtD
Fosphenytoin—Hypertension—Docetaxel—ovarian cancer	0.000451	0.000744	CcSEcCtD
Fosphenytoin—Bronchitis—Doxorubicin—ovarian cancer	0.00045	0.000742	CcSEcCtD
Fosphenytoin—Dyspnoea—Paclitaxel—ovarian cancer	0.000448	0.00074	CcSEcCtD
Fosphenytoin—Somnolence—Paclitaxel—ovarian cancer	0.000447	0.000738	CcSEcCtD
Fosphenytoin—Arthralgia—Docetaxel—ovarian cancer	0.000444	0.000734	CcSEcCtD
Fosphenytoin—Myalgia—Docetaxel—ovarian cancer	0.000444	0.000734	CcSEcCtD
Fosphenytoin—Nausea—Vinorelbine—ovarian cancer	0.000444	0.000733	CcSEcCtD
Fosphenytoin—Renal failure—Epirubicin—ovarian cancer	0.000443	0.000731	CcSEcCtD
Fosphenytoin—Dyspepsia—Paclitaxel—ovarian cancer	0.000442	0.000731	CcSEcCtD
Fosphenytoin—Conjunctivitis—Epirubicin—ovarian cancer	0.000438	0.000723	CcSEcCtD
Fosphenytoin—Dysuria—Doxorubicin—ovarian cancer	0.000437	0.000722	CcSEcCtD
Fosphenytoin—Decreased appetite—Paclitaxel—ovarian cancer	0.000437	0.000721	CcSEcCtD
Fosphenytoin—Dry mouth—Docetaxel—ovarian cancer	0.000435	0.000718	CcSEcCtD
Fosphenytoin—Sweating—Epirubicin—ovarian cancer	0.000432	0.000713	CcSEcCtD
Fosphenytoin—Constipation—Paclitaxel—ovarian cancer	0.00043	0.00071	CcSEcCtD
Fosphenytoin—Confusional state—Docetaxel—ovarian cancer	0.000429	0.000709	CcSEcCtD
Fosphenytoin—Photosensitivity reaction—Doxorubicin—ovarian cancer	0.000427	0.000705	CcSEcCtD
Fosphenytoin—Anaphylactic shock—Docetaxel—ovarian cancer	0.000426	0.000703	CcSEcCtD
Fosphenytoin—Epistaxis—Epirubicin—ovarian cancer	0.000425	0.000702	CcSEcCtD
Fosphenytoin—Infection—Docetaxel—ovarian cancer	0.000423	0.000699	CcSEcCtD
Fosphenytoin—Sinusitis—Epirubicin—ovarian cancer	0.000423	0.000698	CcSEcCtD
Fosphenytoin—Hyperglycaemia—Doxorubicin—ovarian cancer	0.000422	0.000696	CcSEcCtD
Fosphenytoin—Pneumonia—Doxorubicin—ovarian cancer	0.000419	0.000692	CcSEcCtD
Fosphenytoin—Shock—Docetaxel—ovarian cancer	0.000419	0.000692	CcSEcCtD
Fosphenytoin—Thrombocytopenia—Docetaxel—ovarian cancer	0.000417	0.000689	CcSEcCtD
Fosphenytoin—Tachycardia—Docetaxel—ovarian cancer	0.000416	0.000687	CcSEcCtD
Fosphenytoin—Feeling abnormal—Paclitaxel—ovarian cancer	0.000414	0.000684	CcSEcCtD
Fosphenytoin—Bradycardia—Epirubicin—ovarian cancer	0.000412	0.00068	CcSEcCtD
Fosphenytoin—Renal failure—Doxorubicin—ovarian cancer	0.00041	0.000677	CcSEcCtD
Fosphenytoin—Anorexia—Docetaxel—ovarian cancer	0.000406	0.000671	CcSEcCtD
Fosphenytoin—Rhinitis—Epirubicin—ovarian cancer	0.000405	0.00067	CcSEcCtD
Fosphenytoin—Conjunctivitis—Doxorubicin—ovarian cancer	0.000405	0.000669	CcSEcCtD
Fosphenytoin—Hypoaesthesia—Epirubicin—ovarian cancer	0.000402	0.000665	CcSEcCtD
Fosphenytoin—Pharyngitis—Epirubicin—ovarian cancer	0.000401	0.000663	CcSEcCtD
Fosphenytoin—Sweating—Doxorubicin—ovarian cancer	0.0004	0.00066	CcSEcCtD
Fosphenytoin—Urticaria—Paclitaxel—ovarian cancer	0.000399	0.000659	CcSEcCtD
Fosphenytoin—Hypotension—Docetaxel—ovarian cancer	0.000398	0.000657	CcSEcCtD
Fosphenytoin—Body temperature increased—Paclitaxel—ovarian cancer	0.000397	0.000656	CcSEcCtD
Fosphenytoin—Epistaxis—Doxorubicin—ovarian cancer	0.000393	0.000649	CcSEcCtD
Fosphenytoin—Sinusitis—Doxorubicin—ovarian cancer	0.000391	0.000646	CcSEcCtD
Fosphenytoin—Musculoskeletal discomfort—Docetaxel—ovarian cancer	0.000388	0.000641	CcSEcCtD
Fosphenytoin—Insomnia—Docetaxel—ovarian cancer	0.000385	0.000636	CcSEcCtD
Fosphenytoin—Paraesthesia—Docetaxel—ovarian cancer	0.000382	0.000632	CcSEcCtD
Fosphenytoin—Bradycardia—Doxorubicin—ovarian cancer	0.000381	0.000629	CcSEcCtD
Fosphenytoin—Dyspnoea—Docetaxel—ovarian cancer	0.00038	0.000627	CcSEcCtD
Fosphenytoin—Somnolence—Docetaxel—ovarian cancer	0.000379	0.000625	CcSEcCtD
Fosphenytoin—Tinnitus—Epirubicin—ovarian cancer	0.000377	0.000623	CcSEcCtD
Fosphenytoin—Rhinitis—Doxorubicin—ovarian cancer	0.000375	0.00062	CcSEcCtD
Fosphenytoin—Dyspepsia—Docetaxel—ovarian cancer	0.000375	0.000619	CcSEcCtD
Fosphenytoin—Hypoaesthesia—Doxorubicin—ovarian cancer	0.000372	0.000615	CcSEcCtD
Fosphenytoin—Pharyngitis—Doxorubicin—ovarian cancer	0.000371	0.000613	CcSEcCtD
Fosphenytoin—Decreased appetite—Docetaxel—ovarian cancer	0.00037	0.000612	CcSEcCtD
Fosphenytoin—Constipation—Docetaxel—ovarian cancer	0.000364	0.000602	CcSEcCtD
Fosphenytoin—Chills—Epirubicin—ovarian cancer	0.000363	0.000599	CcSEcCtD
Fosphenytoin—Asthenia—Paclitaxel—ovarian cancer	0.000361	0.000595	CcSEcCtD
Fosphenytoin—Pruritus—Paclitaxel—ovarian cancer	0.000356	0.000587	CcSEcCtD
Fosphenytoin—Feeling abnormal—Docetaxel—ovarian cancer	0.000351	0.00058	CcSEcCtD
Fosphenytoin—Tinnitus—Doxorubicin—ovarian cancer	0.000349	0.000576	CcSEcCtD
Fosphenytoin—Flatulence—Epirubicin—ovarian cancer	0.000347	0.000573	CcSEcCtD
Fosphenytoin—Tension—Epirubicin—ovarian cancer	0.000345	0.000571	CcSEcCtD
Fosphenytoin—Dysgeusia—Epirubicin—ovarian cancer	0.000345	0.000569	CcSEcCtD
Fosphenytoin—Diarrhoea—Paclitaxel—ovarian cancer	0.000344	0.000568	CcSEcCtD
Fosphenytoin—Nervousness—Epirubicin—ovarian cancer	0.000342	0.000565	CcSEcCtD
Fosphenytoin—Back pain—Epirubicin—ovarian cancer	0.000341	0.000562	CcSEcCtD
Fosphenytoin—Muscle spasms—Epirubicin—ovarian cancer	0.000338	0.000559	CcSEcCtD
Fosphenytoin—Body temperature increased—Docetaxel—ovarian cancer	0.000337	0.000556	CcSEcCtD
Fosphenytoin—Chills—Doxorubicin—ovarian cancer	0.000336	0.000554	CcSEcCtD
Fosphenytoin—Dizziness—Paclitaxel—ovarian cancer	0.000332	0.000549	CcSEcCtD
Fosphenytoin—Ill-defined disorder—Epirubicin—ovarian cancer	0.000327	0.000539	CcSEcCtD
Fosphenytoin—Anaemia—Epirubicin—ovarian cancer	0.000325	0.000537	CcSEcCtD
Fosphenytoin—Agitation—Epirubicin—ovarian cancer	0.000323	0.000534	CcSEcCtD
Fosphenytoin—Flatulence—Doxorubicin—ovarian cancer	0.000321	0.00053	CcSEcCtD
Fosphenytoin—Tension—Doxorubicin—ovarian cancer	0.00032	0.000528	CcSEcCtD
Fosphenytoin—Vomiting—Paclitaxel—ovarian cancer	0.00032	0.000528	CcSEcCtD
Fosphenytoin—Dysgeusia—Doxorubicin—ovarian cancer	0.000319	0.000527	CcSEcCtD
Fosphenytoin—Malaise—Epirubicin—ovarian cancer	0.000317	0.000524	CcSEcCtD
Fosphenytoin—Rash—Paclitaxel—ovarian cancer	0.000317	0.000523	CcSEcCtD
Fosphenytoin—Dermatitis—Paclitaxel—ovarian cancer	0.000317	0.000523	CcSEcCtD
Fosphenytoin—Nervousness—Doxorubicin—ovarian cancer	0.000316	0.000522	CcSEcCtD
Fosphenytoin—Vertigo—Epirubicin—ovarian cancer	0.000316	0.000522	CcSEcCtD
Fosphenytoin—Syncope—Epirubicin—ovarian cancer	0.000316	0.000521	CcSEcCtD
Fosphenytoin—Leukopenia—Epirubicin—ovarian cancer	0.000315	0.00052	CcSEcCtD
Fosphenytoin—Back pain—Doxorubicin—ovarian cancer	0.000315	0.00052	CcSEcCtD
Fosphenytoin—Headache—Paclitaxel—ovarian cancer	0.000315	0.00052	CcSEcCtD
Fosphenytoin—Muscle spasms—Doxorubicin—ovarian cancer	0.000313	0.000517	CcSEcCtD
Fosphenytoin—Palpitations—Epirubicin—ovarian cancer	0.000311	0.000514	CcSEcCtD
Fosphenytoin—Loss of consciousness—Epirubicin—ovarian cancer	0.000309	0.000511	CcSEcCtD
Fosphenytoin—Cough—Epirubicin—ovarian cancer	0.000307	0.000507	CcSEcCtD
Fosphenytoin—Asthenia—Docetaxel—ovarian cancer	0.000306	0.000505	CcSEcCtD
Fosphenytoin—Convulsion—Epirubicin—ovarian cancer	0.000305	0.000504	CcSEcCtD
Fosphenytoin—Hypertension—Epirubicin—ovarian cancer	0.000304	0.000502	CcSEcCtD
Fosphenytoin—Ill-defined disorder—Doxorubicin—ovarian cancer	0.000302	0.000499	CcSEcCtD
Fosphenytoin—Pruritus—Docetaxel—ovarian cancer	0.000301	0.000498	CcSEcCtD
Fosphenytoin—Anaemia—Doxorubicin—ovarian cancer	0.000301	0.000497	CcSEcCtD
Fosphenytoin—Myalgia—Epirubicin—ovarian cancer	0.0003	0.000495	CcSEcCtD
Fosphenytoin—Arthralgia—Epirubicin—ovarian cancer	0.0003	0.000495	CcSEcCtD
Fosphenytoin—Agitation—Doxorubicin—ovarian cancer	0.000299	0.000494	CcSEcCtD
Fosphenytoin—Nausea—Paclitaxel—ovarian cancer	0.000298	0.000493	CcSEcCtD
Fosphenytoin—Discomfort—Epirubicin—ovarian cancer	0.000296	0.000489	CcSEcCtD
Fosphenytoin—Malaise—Doxorubicin—ovarian cancer	0.000294	0.000485	CcSEcCtD
Fosphenytoin—Dry mouth—Epirubicin—ovarian cancer	0.000293	0.000484	CcSEcCtD
Fosphenytoin—Vertigo—Doxorubicin—ovarian cancer	0.000293	0.000483	CcSEcCtD
Fosphenytoin—Syncope—Doxorubicin—ovarian cancer	0.000292	0.000482	CcSEcCtD
Fosphenytoin—Leukopenia—Doxorubicin—ovarian cancer	0.000292	0.000482	CcSEcCtD
Fosphenytoin—Diarrhoea—Docetaxel—ovarian cancer	0.000291	0.000481	CcSEcCtD
Fosphenytoin—Confusional state—Epirubicin—ovarian cancer	0.00029	0.000478	CcSEcCtD
Fosphenytoin—Palpitations—Doxorubicin—ovarian cancer	0.000288	0.000475	CcSEcCtD
Fosphenytoin—Anaphylactic shock—Epirubicin—ovarian cancer	0.000287	0.000474	CcSEcCtD
Fosphenytoin—Loss of consciousness—Doxorubicin—ovarian cancer	0.000286	0.000473	CcSEcCtD
Fosphenytoin—Infection—Epirubicin—ovarian cancer	0.000285	0.000471	CcSEcCtD
Fosphenytoin—Cough—Doxorubicin—ovarian cancer	0.000284	0.000469	CcSEcCtD
Fosphenytoin—Shock—Epirubicin—ovarian cancer	0.000283	0.000467	CcSEcCtD
Fosphenytoin—Convulsion—Doxorubicin—ovarian cancer	0.000282	0.000466	CcSEcCtD
Fosphenytoin—Dizziness—Docetaxel—ovarian cancer	0.000282	0.000465	CcSEcCtD
Fosphenytoin—Thrombocytopenia—Epirubicin—ovarian cancer	0.000281	0.000465	CcSEcCtD
Fosphenytoin—Hypertension—Doxorubicin—ovarian cancer	0.000281	0.000464	CcSEcCtD
Fosphenytoin—Tachycardia—Epirubicin—ovarian cancer	0.00028	0.000463	CcSEcCtD
Fosphenytoin—Hyperhidrosis—Epirubicin—ovarian cancer	0.000278	0.000459	CcSEcCtD
Fosphenytoin—Arthralgia—Doxorubicin—ovarian cancer	0.000277	0.000458	CcSEcCtD
Fosphenytoin—Myalgia—Doxorubicin—ovarian cancer	0.000277	0.000458	CcSEcCtD
Fosphenytoin—Discomfort—Doxorubicin—ovarian cancer	0.000274	0.000452	CcSEcCtD
Fosphenytoin—Anorexia—Epirubicin—ovarian cancer	0.000274	0.000452	CcSEcCtD
Fosphenytoin—Dry mouth—Doxorubicin—ovarian cancer	0.000271	0.000448	CcSEcCtD
Fosphenytoin—Vomiting—Docetaxel—ovarian cancer	0.000271	0.000447	CcSEcCtD
Fosphenytoin—Rash—Docetaxel—ovarian cancer	0.000269	0.000444	CcSEcCtD
Fosphenytoin—Hypotension—Epirubicin—ovarian cancer	0.000268	0.000443	CcSEcCtD
Fosphenytoin—Dermatitis—Docetaxel—ovarian cancer	0.000268	0.000443	CcSEcCtD
Fosphenytoin—Confusional state—Doxorubicin—ovarian cancer	0.000268	0.000443	CcSEcCtD
Fosphenytoin—Headache—Docetaxel—ovarian cancer	0.000267	0.000441	CcSEcCtD
Fosphenytoin—Anaphylactic shock—Doxorubicin—ovarian cancer	0.000266	0.000439	CcSEcCtD
Fosphenytoin—Infection—Doxorubicin—ovarian cancer	0.000264	0.000436	CcSEcCtD
Fosphenytoin—Musculoskeletal discomfort—Epirubicin—ovarian cancer	0.000262	0.000432	CcSEcCtD
Fosphenytoin—Shock—Doxorubicin—ovarian cancer	0.000262	0.000432	CcSEcCtD
Fosphenytoin—Thrombocytopenia—Doxorubicin—ovarian cancer	0.00026	0.00043	CcSEcCtD
Fosphenytoin—Insomnia—Epirubicin—ovarian cancer	0.00026	0.000429	CcSEcCtD
Fosphenytoin—Tachycardia—Doxorubicin—ovarian cancer	0.000259	0.000428	CcSEcCtD
Fosphenytoin—Paraesthesia—Epirubicin—ovarian cancer	0.000258	0.000426	CcSEcCtD
Fosphenytoin—Hyperhidrosis—Doxorubicin—ovarian cancer	0.000257	0.000424	CcSEcCtD
Fosphenytoin—Dyspnoea—Epirubicin—ovarian cancer	0.000256	0.000423	CcSEcCtD
Fosphenytoin—Somnolence—Epirubicin—ovarian cancer	0.000255	0.000422	CcSEcCtD
Fosphenytoin—Anorexia—Doxorubicin—ovarian cancer	0.000253	0.000418	CcSEcCtD
Fosphenytoin—Nausea—Docetaxel—ovarian cancer	0.000253	0.000418	CcSEcCtD
Fosphenytoin—Dyspepsia—Epirubicin—ovarian cancer	0.000253	0.000418	CcSEcCtD
Fosphenytoin—Decreased appetite—Epirubicin—ovarian cancer	0.00025	0.000412	CcSEcCtD
Fosphenytoin—Hypotension—Doxorubicin—ovarian cancer	0.000248	0.00041	CcSEcCtD
Fosphenytoin—Constipation—Epirubicin—ovarian cancer	0.000246	0.000406	CcSEcCtD
Fosphenytoin—Musculoskeletal discomfort—Doxorubicin—ovarian cancer	0.000242	0.0004	CcSEcCtD
Fosphenytoin—Insomnia—Doxorubicin—ovarian cancer	0.00024	0.000397	CcSEcCtD
Fosphenytoin—Paraesthesia—Doxorubicin—ovarian cancer	0.000239	0.000394	CcSEcCtD
Fosphenytoin—Dyspnoea—Doxorubicin—ovarian cancer	0.000237	0.000391	CcSEcCtD
Fosphenytoin—Feeling abnormal—Epirubicin—ovarian cancer	0.000237	0.000391	CcSEcCtD
Fosphenytoin—Somnolence—Doxorubicin—ovarian cancer	0.000236	0.00039	CcSEcCtD
Fosphenytoin—Dyspepsia—Doxorubicin—ovarian cancer	0.000234	0.000386	CcSEcCtD
Fosphenytoin—Decreased appetite—Doxorubicin—ovarian cancer	0.000231	0.000382	CcSEcCtD
Fosphenytoin—Urticaria—Epirubicin—ovarian cancer	0.000228	0.000377	CcSEcCtD
Fosphenytoin—Constipation—Doxorubicin—ovarian cancer	0.000227	0.000375	CcSEcCtD
Fosphenytoin—Body temperature increased—Epirubicin—ovarian cancer	0.000227	0.000375	CcSEcCtD
Fosphenytoin—Feeling abnormal—Doxorubicin—ovarian cancer	0.000219	0.000362	CcSEcCtD
Fosphenytoin—Urticaria—Doxorubicin—ovarian cancer	0.000211	0.000349	CcSEcCtD
Fosphenytoin—Body temperature increased—Doxorubicin—ovarian cancer	0.00021	0.000347	CcSEcCtD
Fosphenytoin—Asthenia—Epirubicin—ovarian cancer	0.000206	0.00034	CcSEcCtD
Fosphenytoin—Pruritus—Epirubicin—ovarian cancer	0.000203	0.000336	CcSEcCtD
Fosphenytoin—Diarrhoea—Epirubicin—ovarian cancer	0.000197	0.000325	CcSEcCtD
Fosphenytoin—Asthenia—Doxorubicin—ovarian cancer	0.000191	0.000315	CcSEcCtD
Fosphenytoin—Dizziness—Epirubicin—ovarian cancer	0.00019	0.000314	CcSEcCtD
Fosphenytoin—Pruritus—Doxorubicin—ovarian cancer	0.000188	0.000311	CcSEcCtD
Fosphenytoin—Vomiting—Epirubicin—ovarian cancer	0.000183	0.000302	CcSEcCtD
Fosphenytoin—Diarrhoea—Doxorubicin—ovarian cancer	0.000182	0.0003	CcSEcCtD
Fosphenytoin—Rash—Epirubicin—ovarian cancer	0.000181	0.000299	CcSEcCtD
Fosphenytoin—Dermatitis—Epirubicin—ovarian cancer	0.000181	0.000299	CcSEcCtD
Fosphenytoin—Headache—Epirubicin—ovarian cancer	0.00018	0.000297	CcSEcCtD
Fosphenytoin—Dizziness—Doxorubicin—ovarian cancer	0.000176	0.00029	CcSEcCtD
Fosphenytoin—Nausea—Epirubicin—ovarian cancer	0.000171	0.000282	CcSEcCtD
Fosphenytoin—Vomiting—Doxorubicin—ovarian cancer	0.000169	0.000279	CcSEcCtD
Fosphenytoin—Rash—Doxorubicin—ovarian cancer	0.000168	0.000277	CcSEcCtD
Fosphenytoin—Dermatitis—Doxorubicin—ovarian cancer	0.000167	0.000277	CcSEcCtD
Fosphenytoin—Headache—Doxorubicin—ovarian cancer	0.000167	0.000275	CcSEcCtD
Fosphenytoin—Nausea—Doxorubicin—ovarian cancer	0.000158	0.000261	CcSEcCtD
